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ABSTRACT
Objectives: To determine how ‘overdiagnosis’ is
currently conceptualised among adults in the UK in light
of previous research, which has found that the term is
difficult for the public to understand and awareness is
low. This study aimed to add to current debates on
healthcare in which overdiagnosis is a prominent issue.
Design: An observational, web-based survey was
administered by a survey company.
Setting: Participants completed the survey at a time
and location of their choosing.
Participants: 390 consenting UK adults aged
50–70 years. Quota sampling was used to achieve
approximately equal numbers in three categories of
education and equal numbers of men and women.
Primary outcome measures: Participants were
asked whether they had seen or heard the term
‘overdiagnosis’. If they had, they were then invited to
explain in a free-text field what they understood it to
mean. If they had not previously encountered it, they
were invited to say what they thought it meant.
Responses were coded and interpreted using content
analysis and descriptive statistics.
Results: Data from 390 participants were analysed.
Almost a third (30.0%) of participants reported having
previously encountered the term. However, their
responses often indicated that they had no knowledge
of its meaning. The most prevalent theme consisted of
responses related to the diagnosis itself. Subthemes
indicated common misconceptions, including an
‘overly negative or complicated diagnosis’, ‘false-
positive diagnosis’ or ‘misdiagnosis’. Other recurring
themes consisted of responses related to testing (ie,
‘too many tests’), treatment (eg, ‘overtreatment’) and
patient psychology (eg, ‘overthinking’). Responses
categorised as consistent with ‘overdiagnosis’ (defined
as detection of a disease that would not cause
symptoms or death) were notably rare (n=10; 2.6%).
Conclusions: Consistent with previous research,
public awareness of ‘overdiagnosis’ in the UK is low and
its meaning is often misunderstood or misinterpreted.
INTRODUCTION
Academics, healthcare professionals and
policymakers are becoming increasingly con-
cerned about circumstances in which the
health beneﬁts of a given intervention
are not considered to clearly justify the
associated risks. The British Medical Journal
has been a prominent voice in this area
through their ‘Too Much Medicine’ cam-
paign,1 which has recently gained support
from the Academy of Medical Royal
Colleges.2 A central topic within the cam-
paign is ‘overdiagnosis’, deﬁned here as the
diagnosis of disease which would never have
become clinically apparent in a person’s life-
time (ie, causing neither symptoms nor
death).3 4 Debate continues regarding the
magnitude, signiﬁcance and implications of
overdiagnosis. Much attention is focused on
breast cancer screening, where estimates of
the ratio of screening-prevented breast
cancer deaths to overdiagnosed breast
cancer cases range from 9:45 to 5:173 for
1000 women screened over 20 years. There is
also an increasingly common view that
screening invitees should appreciate the pos-
sibility of overdiagnosis before deciding
whether to participate,6 although there is
professional controversy regarding how best
to inform people about the concept.7
Public awareness of overdiagnosis appears
to be low in many countries. A study from
2000 in the USA found that only a small
minority (7%) of women were aware of the
concept of non-progressive breast cancer.8
Recently, a focus group study in Korea found
that women had difﬁculty understanding the
meaning of overdiagnosis in the context of
Strengths and limitations of this study
▪ This is the first study to investigate how the UK
general public understands and interprets the
term ‘overdiagnosis’.
▪ Free-text fields allowed participants to respond in
their own words without being limited to cat-
egories preselected by the researchers.
▪ The results of this study corroborate those of a
previous survey in Australia and are consistent
with previous research indicating that overdiagno-
sis is a difficult concept for people to understand.
▪ An appreciable proportion of participants’
responses were ambiguous in their meaning and
some could not be coded into a specific category.
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thyroid cancer screening.9 Very similar ﬁndings have
been reported in a small interview study about breast
cancer screening based in Denmark.10 In addition,
Moynihan and colleagues recently reported a survey of
500 Australian adults drawn from the general popula-
tion, who were asked to state whether they had seen or
heard the term, before indicating what they thought it
meant. The majority (50–63%) reported having encoun-
tered the term before, but only 41% of the sample were
categorised as responding with even an approximately
correct deﬁnition of the term. Participants categorised
as being approximately correct often described it in
terms of misdiagnosis, too many diagnoses or overstating
the signiﬁcance of a diagnosis, with 35% of responses
falling into one of these categories.11 Although these
have some similarities with the intended meaning of
overdiagnosis, there is an apparent lack of awareness
regarding its speciﬁc meaning. This suggests that despite
attention in health-related literature, overdiagnosis has
not become a familiar term among the general public.
The present study extends the previous work by
exploring people’s deﬁnitions of ‘overdiagnosis’ as part
of a web-based survey of adults in the UK. We used the
same measures of awareness as Moynihan et al11 to allow
comparability between studies.
METHODS
This study took place as part of a web-based survey of
attitudes and beliefs about cancer in February 2015. The
sample consisted of consenting members of the UK
general population aged 50–70 years, recruited through
a survey company (Survey Sampling International, SSI).
SSI maintains a panel of potential survey participants;
these individuals are periodically invited to complete
online surveys in exchange for small amounts of com-
pensation (eg, air miles) via a generic recruitment
email. The email contained a link that directed partici-
pants to the online survey. Quotas were used to ensure
an equal proportion of men and women, and equal pro-
portions of participants with different levels of education
(three categories: leaving school before 16 years; com-
pleting CSEs, O-levels or equivalent; completing A-levels,
higher, university education or equivalent).
As in the Australian study, participants were ﬁrst asked:
‘have you seen or heard the term “overdiagnosis” before
today’. Those responding ‘yes’ were then asked ‘what do
you understand the term “overdiagnosis” to mean’;
those who responded ‘no’ were asked ‘what do you
think the term “overdiagnosis” means’.i Participants
responded to the latter two questions by completing a
free-text ﬁeld. They were also asked for basic demo-
graphic information (gender, age, level of education
and ethnicity).
The questions on overdiagnosis formed part of a
larger survey on views relating to cancer screening;
hence, participants were selected to be approaching or
at an age at which they would be eligible for breast or
colorectal cancer screening in the UK.
Screening-speciﬁc questions always came after questions
on overdiagnosis, and so responses could not have been
inﬂuenced by the questions on screening (results not
reported here).
Demographic data and self-reported recognition of
the term ‘overdiagnosis’ were analysed using simple
descriptive statistics. Content analysis was used to
examine responses to free-text questions.12 Responses
were categorised independently by two researchers (AG
and SFM), who read participants’ answers repeatedly
before assigning a provisional code (eg, misdiagnosis) to
each one, based on their interpretation. After both
researchers had completed their separate coding, the
two lists were compared and disagreements resolved
through discussion. The ﬁnal list of codes was then
reviewed to determine whether several codes could be
meaningfully renamed, grouped together or split into
further codes. The overarching themes and speciﬁc sub-
themes identiﬁed were then summarised using descrip-
tive statistics and illustrated using exemplar quotes.
Responses of participants who reported having seen or
heard the term before and those of participants who
reported no previous exposure to the term were
reported separately.
RESULTS
Participant characteristics
The sample comprised 390 adults (201 women; 51.5%)
with a median age of 60 years (interquartile range
(IQR) 55–65). Most stated their ethnicity as Caucasian
(n=382; 97.9%). Per our quota sampling, approximately
equal numbers had left school before 16 years (133;
34.1%), completed CSEs, O-levels or equivalent (125;
32.1%), and had completed A-levels, higher, or univer-
sity degree, or equivalent (132; 33.8%).
Definitions of ‘overdiagnosis’
One hundred and seventeen participants (30.0%)
reported having seen or heard the term previously.
Median length of free-text responses relating to partici-
pants’ understanding was seven words (range 1–42; IQR
4–12.5); for responses from participants who had not
seen or heard it before, it was four words (range 1–28;
IQR 2–8).
Responses are presented separately for those who had
and those who had not previously encountered the
term. For both groups, responses could be categorised
into one of six broad themes. These are summarised in
iAn error in the skip logic of the survey meant that participants who
responded ‘yes’ were also asked the second question. Hence, data on
questions asked in error were not analysed since participants often
responded with the same answer or noted that they had already
answered a very similar question. One participant who responded ‘no’
was able to complete both questions and so was excluded from the
analysis since their answer to the second (correctly asked) question
may have been affected by the ﬁrst (incorrectly asked) question.
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table 1 (for participants who had previously encoun-
tered the term) and table 2 (for those who had not),
respectively, along with exemplar quotes. Participants
commonly reported either no knowledge of what the
term meant (even when they reported having encoun-
tered it before) or responded in a way that could not be
categorised (frequently because the response was too
vague or entirely unclear). Three other themes were
aligned with different stages of a patient trajectory: from
testing (too many tests) to diagnosis, and treatment. The
theme relating to diagnosis was the most prevalent;
38.5% and 26.1% of responses from participants who
had and had not been previously exposed to the term
were categorised into this theme. Relevant subthemes
included an ‘overly negative or complicated diagnosis’, a
‘false-positive diagnosis’ and a ‘misdiagnosis’.
Treatment-related responses referred to ‘overtreatment’,
‘inappropriate treatment’ and ‘unbeneﬁcial treatment’.
A further broad theme referred to conceptions of how
patients’ psychology related to overdiagnosis, with the
most common subtheme being ‘overthinking’. The ﬁnal
grouping consisted of other responses that could not be
categorised into one of the preceding ﬁve themes.
Responses were rarely consistent with ‘overdiagnosis’
itself, whether or not participants had previously been
exposed to the term (n=9, 7.7%; n=1, 0.4%). All such
responses are reported in box 1.
DISCUSSION
This survey of deﬁnitions of ‘overdiagnosis’ among
adults in the UK found that despite approximately one
in three people stating that they had seen or heard the
term before, only a minority (2.6% of all participants)
provided a response that was even broadly consistent
with the meaning considered correct: diagnosis of a
disease that would not cause symptoms or death.3 This
ﬁnding can be interpreted in light of the inconsistent
usage of the term among academics and clinicians. As
Carter et al4 note, the intended meaning can vary,
depending on the speciﬁc context being addressed
within the general domain of ‘Too Much Medicine’. For
Table 1 Understanding of ‘overdiagnosis’ among participants who had previously encountered the term (n=117): emerging
(sub)themes
Category Exemplar quote (spelling errors corrected) n (%)
Response not categorised or no knowledge
Incoherent, irrelevant or too vague
to interpret
“More than a person says.” 21 (17.9)
No knowledge “Not sure.” 10 (8.5)
Diagnosis-related responses
Overly negative or complicated
diagnosis
“Where certain illnesses are overstated in their severity.” 12 (10.3)
False-positive diagnosis “Diagnosis of a condition that is not really there.” 11 (9.4)
Overdiagnosis “I think it means the diagnosis of a disease that will not cause symptoms
or death.”
9 (7.7)
Too many diagnoses “Finding out all the complaints that may be wrong with you.” 8 (6.8)
Overly detailed diagnosis “A condition has been over-described.” 4 (3.4)
Misdiagnosis “Diagnosing minor problems rather than the real problem at source.” 1 (0.9)
Diagnosis based on stereotypes “Diagnosis based on stereotypes e.g. The patient is overweight therefore
he will have a CVA.”
1 (0.9)
Test-related responses
Too many tests “Patient undergoing more tests than necessary to diagnose a disease.” 6 (5.1)
Treatment-related responses
Inappropriate treatment “Taking medicine not needed.” 1 (0.9)
Overtreatment “Had taken too many pills, or dr. prescribe too many different pills the
person must take, when don’t need.”
1 (0.9)
Responses related to patients’ psychology
Overthinking “When you think things through to such an extent that you confuse things
or make them more complicated or important than they deserve to be.”
20 (17.1)
Overly health-sensitive “Over-analysing of minor conditions until you are convinced that there is a
condition to be treated.”
4 (3.4)
Anticipating a worse diagnosis “Presuming something nasty is wrong before running tests.” 3 (2.6)
Other responses
Medicalising issues unrelated to
health
“When non-health-related issues are medicalised.” 2 (1.7)
Defensive medicine “Must have an answer, doctors not wanted to be sued.” 1 (0.9)
Iatrogenic illness “Iatrogenic illness” 1 (0.9)
Too many attempts at prevention “Too much preventing what may happen or not.” 1 (0.9)
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example, the term may be used to describe detection
of ‘incidentalomas’ in lung cancer screening,13 or
diagnosis due to diagnostic criteria being expanded
(eg, pre-diabetes14 and attention-deﬁcit/hyperactivity
disorder15). Hence, it is not surprising that a single clear
meaning has not reached public awareness. However,
concerns regarding overdiagnosis are likely to be an
increasingly inﬂuential aspect of both policy-level and
patient-level decisions. Consequently, policymakers,
healthcare providers and communicators may consider
this to be an important concept that the public should
understand. One risk of a lack of awareness is scepticism
regarding the true purpose of an attempt to reduce the
delivery healthcare interventions (eg, the belief that it is
an attempt to reduce costs). This may account for the
generally negative views among women regarding the
US Preventive Services Task Force (USPSTF) recommen-
dation that women aged 40–49 should not undergo
routine mammography screening16 17 and it might be
hypothesised that there are similar negative perceptions
among men regarding the USPSTF recommendation
against prostate-speciﬁc antigen screening in 2012.18
The present ﬁndings indicate that there is substantial
potential to increase public awareness.
After excluding responses that could not be cate-
gorised and those where participants stated they had no
knowledge, the most commonly occurring themes were
related to diagnosis, including an ‘overly negative or
complicated diagnosis’, or a ‘false-positive diagnosis’.
These ﬁndings are similar to those of the Australian
survey,11 in which 22% thought it meant exaggerating
an existing condition and 10% thought it meant diag-
nosing a non-existent condition. The patient-related sub-
themes such as ‘overthinking’ were more surprising,
showing that patients do not necessarily only consider
the healthcare provider’s or the healthcare system’s
responsibility in inﬂuencing overdiagnosis, but also rec-
ognise the possible inﬂuence of patient attitudes towards
health and illness. Some previous studies19 have pro-
vided participants with information that aims to clarify
the distinction between overdiagnosis and false positives;
the present ﬁndings suggest that there may be additional
assumptions to be addressed.
Our ﬁndings are also consistent with discussion group
studies in the UK and Australia where the term ‘over-
diagnosis’ was explained to lay members of the public in
the context of breast cancer screening. These studies
reported that most participants found the term counter-
intuitive, in part because it involved understanding that
some medical conditions, including cancer, will never
cause harm.20 21 The term was also seen as difﬁcult for
participants to understand. Participants were given
detailed information on overdiagnosis using a method
that allowed them to ask and receive answers to ques-
tions that arose. However, when asked a multiple choice
question on the most applicable deﬁnition, 16% gave an
incorrect answer and a further 24% gave only a partially
correct answer.20 Comparable trends have also been
Table 2 Interpretation of ‘overdiagnosis’ among participants who had not previously encountered the term (n=273):
emerging (sub-)themes
Category Exemplar quote (spelling errors corrected) n (%)
Response not categorised or no knowledge
No knowledge “Don’t know.” 103 (37.7)
Incoherent, irrelevant or too vague to
categorise
“Going over the top.” 44 (16.1)
Diagnosis-related responses
Overly negative or complicated diagnosis “Diagnosing a disease to a worse state than actual.” 30 (11.0)
False-positive diagnosis “It sounds like being told you have things you don’t have.” 13 (4.8)
Misdiagnosis “The wrong diagnosis of an illness.” 12 (4.4)
Overly detailed diagnosis “Too much information on a probable problem.” 9 (3.3)
Too many diagnoses “Too many different diagnosis from various medical professionals.” 6 (2.2)
Overdiagnosis “Making People Sick in the Pursuit of Health.” 1 (0.4)
Test-related responses
Too many tests “Too many health checks.” 6 (2.2)
Treatment-related responses
Overtreatment “Treating an illness in a stronger way than necessary.” 6 (2.2)
Inappropriate treatment “Wrong treatment or pills.” 2 (0.7)
Unbeneficial treatment “Giving medical assistance when there is no hope.” 1 (0.4)
Responses related to patients’ psychology
Overthinking “Complicating a problem by thinking too much about it.” 15 (5.5)
Overly health-sensitive “Worrying too much about health issues, continually seeking
explanations.”
10 (3.7)
Anticipating a worse diagnosis “Looking at worst case scenario before having all the facts.” 8 (2.9)
Other responses
Multiple (medical) opinions “Too many people involved in a medical decision.” 5 (1.8)
Defensive medicine “Treatment, just to be on the safe side.” 2 (0.7)
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seen in both quantitative8 and qualitative studies9 10
from other countries, which have reported both low
levels of awareness and difﬁculty understanding the
term.
This study has limitations. Coding of participants’ deﬁ-
nitions necessarily relied on the authors’ interpretations
of brief free-text responses, and so the reader may dis-
agree with some of our coding. Furthermore, as previ-
ously noted, there is continuing academic debate
regarding the most appropriate deﬁnition of overdiagno-
sis.4 22 In addition, some responses coded as consistent
with overdiagnosis also contained misconceptions (eg,
relating to false positives). In these cases, the most
appropriate code to use was ambiguous. Similarly, the
brevity of participants’ responses precluded an in-depth
understanding of their intended meanings, resulting in
categories that warrant further exploration. In particular,
participants’ ideas regarding ‘overthinking’ may have
been related to the source and context in which they
encountered the term but these factors were not
recorded in the present study. There was also an appre-
ciable proportion of responses that could not be coded.
Future qualitative research could be undertaken to
address this. Future research could also evaluate
whether alternative terminology (eg, overdetection)19
would be more intuitive to participants, resulting in a
greater proportion of correct interpretations. Finally,
survey response rates were not available from the survey
company, creating uncertainty regarding the representa-
tiveness of the sample.
In conclusion, this study found that ‘overdiagnosis’
was rarely deﬁned correctly by the public, indicating sub-
stantial scope to increase awareness. Future research
should be designed with an assumption of extremely low
pre-existing knowledge of the concept in the general
population.
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